More tolerable treatment for severe, obstructive sleep apnea around the world

June 15, 2000

While the most effective treatment for severe, obstructive sleep apnea is a tracheotomy, many people decline to have the operation because they loathe the idea of having a quarter sized opening in their neck. Now, a study in the June issue of American Journal of Respiratory and Critical Care Medicine proves that a tiny 2 millimeter opening can work as well when combined with a new technology to monitor the flow of air. The finding may lead to new treatments in the future.

"This study gives us a new approach to supporting ventilation in patients with sleep apnea and other kinds of breathing disorders," says Alan Schwartz, M.D., associate professor of pulmonary medicine at Johns Hopkins and lead author of the study. "This approach is potentially far more tolerable."

Obstructive sleep apnea, a common condition, occurs when air cannot flow properly through a person's nose or mouth. Triggered by problems such as excess tissue in the airway, the condition seriously disturbs normal sleep and causes fatigue. Oral devices and surgeries can remedy the problem, but the most common therapy is continuous positive airway pressure (CPAP). CPAP, used during sleep, provides a stream of air to the throat via a mask and pump. It keeps structures from blocking the air passage. But when a person with severe apnea cannot tolerate the mask or other treatments fail, doctors recommend tracheotomies. Many patients, however, refuse the operation, aghast at the size of the necessary opening surgeons must leave in the neck.

For the past 10 or 15 years, the so called "mini tracheotomy" has been available for emphysema patients and others who need extra oxygen. To see if this therapy could also be used for sleep apnea, Schwartz's team enlisted five apneic patients who had undergone large tube tracheotomies. The researchers placed caps over the existing holes and slid skinny tubing through the caps to simulate mini tracheotomies. The doctors then monitored the patients' breathing patterns during sleep.

The researchers discovered that a greater flow of air is needed to avoid apnea than merely to provide extra oxygen. A higher flow rate, however, sometimes closed patients' vocal chords and increased tracheal pressure.

To avoid this problem, doctors developed a computer-controlled flow delivery device that monitored tracheal pressure and varied the flow of air appropriately. Patients hooked up to a computer running the newly designed program were able to successfully avoid apnea.

"Based on our clinical experience, we know that many people cannot use the CPAP mask but refuse to have a tracheotomy because they cannot stand the thought of having a big hole in their neck," says Schwartz. "We need other options for treating severely affected patients and this study shows a new, potentially more tolerable approach." In the future, the doctors hope to make this device available to the public by fitting their program onto a tiny microchip. This microchip will be attached to the tracheotomy itself, making a separate computer unnecessary. According to statistics from the National Institutes of Health, obstructive sleep apnea afflicts an estimated 18 million Americans. In a given night, a person can have as many as 100 or more involuntary breathing pauses per hour. The frequent interruptions of deep sleep often lead to early morning headaches and grogginess during the day. Consequences of the condition include depression, irritability, sexual dysfunction, and difficulties with learning and memory. It can also cause a person to fall asleep randomly, while at work or driving a car for example, and is associated with irregular heartbeat, high blood pressure, heart attack, and stroke.
Other authors of the study include Daniel J. O'Hearn, Karen LeBlanc, Philip L. Smith, Christopher P. O'Donnell, and David W. Eisele from Johns Hopkins; and Hartmut Schneider and J. H. Peter from Philipps-Universitat Marburg in Marburg, Germany.

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at , at Newswise at and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to .

On a POST-EMBARGOED basis find them at , Quadnet at and ScienceDaily at

Johns Hopkins Medicine

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to